Question 1

What is Herceptin used for?

Accepted Answer

Herceptin (trastuzumab) is a biologic drug that revolutionized the treatment of HER2-positive cancers. It specifically targets and binds to the HER2 receptors found on the surface of certain cancer cells, helping to slow or stop their growth. It is not a general chemotherapy drug but rather a targeted therapy, used both alone and in combination with chemotherapy agents.


 	
HER2-positive breast cancerHerceptin is most commonly used in women and men diagnosed with early-stage or metastatic breast cancer that overexpresses the HER2 protein, a known marker for aggressive cancer growth.

 	
HER2-positive gastric and gastroesophageal cancersIt is approved for use in advanced gastric cancers that also overexpress HER2, often as part of a chemotherapy regimen including cisplatin and capecitabine or 5-fluorouracil.

 	
Adjuvant therapy post-surgeryIn early-stage HER2+ breast cancer, Herceptin may be used after surgery to help prevent the recurrence of cancer by eliminating residual microscopic cells.

 	
Neoadjuvant therapy before surgeryIt may also be administered before surgery to shrink tumors, improving the success of surgical intervention and reducing the need for mastectomy.

 	
Maintenance treatmentAfter initial chemotherapy and surgery, Herceptin can be continued as a long-term maintenance therapy to keep the cancer in remission.

 	
Used in both metastatic and non-metastatic casesWhether cancer has spread or remains localized, Herceptin plays a key role in controlling disease progression in HER2-overexpressing tumors.

Question 2

How does Herceptin work in the body?

Accepted Answer

Herceptin is a monoclonal antibody that attaches to the HER2 receptor — a protein found in high amounts on the surface of certain cancer cells. By binding to this receptor, Herceptin disrupts cellular communication that promotes cancer cell division and also alerts the immune system to attack those cells.


 	
HER2 receptor blockadeHerceptin binds to the extracellular domain of the HER2 protein, preventing it from sending growth signals to the cancer cell's nucleus.

 	
Inhibits cell proliferationBy blocking HER2-driven signaling, it prevents cells from entering the replication phase, effectively halting the uncontrolled growth that characterizes cancer.

 	
Immune system activation (ADCC)Herceptin flags cancer cells for destruction by the body’s natural defense mechanisms, particularly natural killer cells, in a process called antibody-dependent cellular cytotoxicity.

 	
Inhibits angiogenesisSome studies suggest that Herceptin reduces the formation of new blood vessels around the tumor, restricting its access to nutrients and oxygen.

 	
Prevents HER2 receptor dimerizationIt interferes with the pairing of HER2 receptors with themselves or other receptor types, further inhibiting signaling pathways.

 	
Works synergistically with chemotherapyWhen combined with drugs like docetaxel or paclitaxel, Herceptin enhances the overall cytotoxic effect on tumors, leading to better response rates.

Question 3

How is Herceptin administered?

Accepted Answer

Herceptin is not a pill or a self-injectable medication. It is administered as an intravenous infusion in a clinical setting under the supervision of trained medical personnel. The dosage, frequency, and duration of treatment depend on your diagnosis, body weight, and whether it’s being used alone or with other medications.


 	
Administered via IV infusionThe reconstituted drug is diluted in saline and infused into a vein over a specific period, typically in a hospital or clinic.

 	
Loading dose followed by maintenance dosesTreatment often starts with a larger initial dose (loading dose), followed by smaller maintenance doses every one to three weeks.

 	
Premedication may be requiredTo prevent infusion-related reactions, patients may be premedicated with antihistamines or corticosteroids before their infusion.

 	
Infusion time variesThe first infusion usually takes 90 minutes, while subsequent doses may be administered over 30 to 60 minutes, depending on tolerance.

 	
Frequency of administrationHerceptin is often given every week or every three weeks. The three-week schedule is more common for outpatient convenience.

 	
Reconstitution in sterile conditionsThe lyophilized powder must be prepared in a sterile environment, ensuring the right dilution and preservation of drug integrity.

 	
Monitoring during and after infusionVital signs and symptoms are closely observed during and for a short time after administration to detect allergic or infusion-related reactions.

Question 4

What precautions should I take when using Herceptin?

Accepted Answer

Because Herceptin targets the HER2 receptor in a precise but powerful way, it can impact other organs — especially the heart — and may interact with other medications. Patients must be screened and monitored throughout the treatment course to ensure safety.


 	
Baseline and ongoing heart function monitoringHerceptin can weaken heart muscle (cardiotoxicity). Echocardiograms or MUGA scans are used to check left ventricular ejection fraction before and during treatment.

 	
Avoid during pregnancyHerceptin can harm fetal development, especially during the second and third trimesters. It should not be used during pregnancy, and contraception is required during and for at least 7 months after treatment.

 	
Monitor for signs of infusion reactionChills, fever, difficulty breathing, or rash during infusion may indicate an allergic or hypersensitivity reaction requiring immediate medical intervention.

 	
Blood work is essentialRoutine blood tests monitor liver enzymes, kidney function, and immune cell levels to detect any early signs of toxicity or organ stress.

 	
Disclose all medicationsPatients should inform their healthcare providers about all drugs they’re taking, especially anthracyclines (e.g., doxorubicin), as the combined use increases heart risks.

 	
Post-treatment fertility planningWomen wishing to conceive after treatment should consult fertility specialists, as the drug may temporarily or permanently affect reproductive function.

Question 5

What are the common side effects of Herceptin?

Accepted Answer

Herceptin is generally well-tolerated, but like all biologic therapies, it comes with potential side effects that vary in severity. Most side effects are manageable with premedication or dose adjustments, but some require careful monitoring and intervention.


 	
Infusion-related reactionsThese are the most frequently reported side effects and include fever, chills, nausea, headache, and rash. They typically occur with the first few doses and diminish over time.

 	
Cardiac complicationsReduced heart pumping function (left ventricular dysfunction) or congestive heart failure can occur, especially in older patients or those on concurrent anthracycline therapy.

 	
Respiratory issuesCough, shortness of breath, and interstitial lung disease are rare but serious side effects that require immediate medical attention.

 	
Gastrointestinal disturbancesDiarrhea, nausea, and vomiting may occur, particularly when Herceptin is used in combination with chemotherapy agents.

 	
Fatigue and weaknessMany patients experience general tiredness or lack of energy, which may worsen as treatment progresses.

 	
Muscle or joint painArthralgia and myalgia can arise in some patients, often manageable with over-the-counter pain relievers.

 	
Skin reactionsDry skin, itching, or mild rashes can appear, especially with long-term use.

Question 6

Does Herceptin require refrigeration during shipping?

Accepted Answer

Yes, Herceptin is a temperature-sensitive medication and must be shipped and stored under strict cold-chain conditions to preserve its chemical stability and therapeutic effectiveness. Exposure to high or freezing temperatures can degrade the product, rendering it ineffective or unsafe for use. At NovaScript Pharmacy, we take this responsibility seriously and ensure compliance with pharmaceutical shipping standards.


 	
Required storage temperature is 2°C to 8°CHerceptin must be refrigerated at all times during storage and transport. Any deviation from this range compromises the integrity of the monoclonal antibody.

 	
Do not freezeFreezing the product can cause irreversible damage to the protein structure, making it unsafe for patient use.

 	
We provide insulated shipping containersOur packaging includes medical-grade thermal insulation and cold packs to maintain a consistent temperature throughout transit.

 	
Shipment includes real-time temperature indicatorsFor sensitive routes or high-risk zones, we incorporate temperature indicators to ensure compliance from dispatch to delivery.

 	
Delivered within a guaranteed time frameWe prioritize express shipping (usually overnight) to minimize transit time and avoid temperature excursions.

 	
Instructions provided upon deliveryOnce received, customers are advised to immediately place the vials in a refrigerator to continue proper storage.

Question 7

Can I take Herceptin without chemotherapy?

Accepted Answer

While Herceptin is often used alongside chemotherapy to enhance cancer-killing effects, it is sometimes prescribed as a standalone therapy. This depends entirely on the type and stage of cancer, as well as the patient’s individual response to prior treatment. Doctors evaluate multiple clinical factors before deciding on monotherapy.


 	
Standalone use is common in maintenance therapyAfter completing chemotherapy, patients often continue with Herceptin alone to reduce recurrence risk, particularly in early-stage breast cancer.

 	
Also used alone in select low-risk patientsIn some cases of HER2-positive tumors with favorable prognostic indicators, Herceptin monotherapy may be considered sufficient.

 	
Combination improves efficacy in aggressive casesFor high-grade or metastatic tumors, Herceptin is typically combined with agents like paclitaxel, carboplatin, or docetaxel for a synergistic effect.

 	
Reduced toxicity when used alonePatients who cannot tolerate chemotherapy due to comorbidities or advanced age may receive Herceptin alone to minimize side effects.

 	
Not suitable for all HER2-positive cancersDecisions about monotherapy versus combination therapy are made based on HER2 expression levels, hormone receptor status, tumor size, and lymph node involvement.

 	
Regular imaging and lab monitoring still requiredEven when used alone, Herceptin necessitates close surveillance to assess tumor response and manage potential adverse effects.

Question 8

Is Herceptin available as a biosimilar?

Accepted Answer

Yes, Herceptin has several biosimilars that are approved by regulatory authorities like the FDA and EMA. These biosimilars are designed to be highly similar to the original biologic (Herceptin) in terms of safety, purity, and efficacy. At NovaScript Pharmacy, we can supply both original Herceptin and approved biosimilar versions upon request.


 	
FDA- and EMA-approved biosimilars availableExamples include Ogivri (trastuzumab-dkst), Kanjinti (trastuzumab-anns), Trazimera (trastuzumab-qyyp), and Herzuma (trastuzumab-pkrb).

 	
Clinically equivalent to the originalExtensive studies have shown that these biosimilars have no meaningful differences from Herceptin in terms of safety, potency, or immunogenicity.

 	
Significantly lower in costBiosimilars typically cost 15–30% less than the original, making them more accessible, especially in low-income regions or for uninsured patients.

 	
Same dosage forms and administration routesBiosimilars come in the same vial configurations and require the same preparation and infusion procedures as Herceptin.

 	
Approved for the same indicationsAll authorized biosimilars are approved for HER2-positive breast and gastric cancers, both in early-stage and metastatic settings.

 	
Regulatory oversight ensures safetyBiosimilars undergo rigorous quality checks and post-marketing surveillance to ensure ongoing safety and efficacy in real-world use.

Question 9

What should I do if I miss a dose?

Accepted Answer

Missing a Herceptin dose should be addressed as quickly as possible since delays in administration can impact treatment effectiveness — especially in aggressive or metastatic cancers. It is important not to try rescheduling the dose yourself but to consult with a qualified healthcare provider.


 	
Contact your oncologist or infusion center immediatelyThey will determine whether to administer the missed dose or adjust the schedule for subsequent treatments.

 	
Avoid doubling the next doseHerceptin does not work like oral medications — extra doses do not compensate for missed infusions and could be harmful.

 	
Impact of missed doses variesMissing a dose early in the treatment cycle can be more significant than missing one later. Your doctor will evaluate the clinical impact based on timing and cancer stage.

 	
Some flexibility is built into treatment windowsDepending on the specific protocol, infusions may be delayed by a few days without major consequences, but this must be evaluated on a case-by-case basis.

 	
Maintain consistent communication with your providerAlways inform your treatment team of travel plans, illnesses, or side effects that might cause delays so they can plan accordingly.

 	
Adherence improves outcomesPatients who stick to the recommended schedule generally have better long-term survival and disease-free progression rates.

Question 10

Can Herceptin be used for men?

Accepted Answer

Although breast cancer is less common in men, Herceptin is approved for use in male patients with HER2-positive cancers. It offers the same benefits as in women and is administered using identical protocols. Additionally, it is also used in men for HER2-overexpressing gastric cancers.


 	
Approved for male breast cancerMen with HER2-positive breast cancer can benefit from Herceptin, whether early-stage or metastatic, just as female patients do.

 	
Effective in male gastric cancersHER2-positive stomach or gastroesophageal cancers in men respond to Herceptin when used in combination with chemotherapy.

 	
No gender-specific pharmacokineticsHerceptin works the same in male and female bodies; there is no difference in dosing, administration, or therapeutic action.

 	
Clinical trials include male patientsThough a smaller population, men have been included in studies demonstrating the drug's efficacy and safety.

 	
Monitoring requirements remain the sameCardiac and liver function monitoring, side effect profile, and infusion precautions are identical for both genders.

 	
Male patients should be offered genetic testingHER2 testing is essential before prescribing Herceptin, and genetic counseling may be recommended based on family history.

Question 11

How long will I need to take Herceptin?

Accepted Answer

The duration of Herceptin therapy varies depending on the type and stage of cancer being treated, whether the patient is in an adjuvant or metastatic setting, and how well the patient tolerates the drug. Treatment duration is typically determined by your oncologist based on clinical guidelines and response to therapy.


 	
Standard duration for early-stage breast cancer is 12 monthsIn most early-stage HER2-positive breast cancer cases, Herceptin is prescribed for a total of one year, either alone or alongside chemotherapy.

 	
Shorter regimens possible in select patientsIn some low-risk cases, a 6-month treatment course may be considered effective, particularly for patients with low tumor burden or those experiencing significant side effects.

 	
Extended treatment for metastatic diseasePatients with metastatic HER2-positive cancer may remain on Herceptin indefinitely if they continue to respond and tolerate the medication well.

 	
Treatment may be paused for toxicityIf heart-related or other serious side effects occur, the medication may be paused temporarily or stopped entirely based on the severity of the reaction.

 	
Disease recurrence may restart treatmentIf the cancer returns after remission, Herceptin may be reintroduced as part of a new therapeutic regimen.

 	
Treatment cycles can include breaksFor long-term use, oncologists may schedule breaks or alternate therapies to reduce cumulative side effects and maintain drug effectiveness.

Question 12

Are there risks of long-term Herceptin use?

Accepted Answer

While Herceptin has been proven to be both effective and safe, long-term or continuous use can carry risks — particularly involving the heart and immune system. These risks are closely monitored by oncologists throughout the treatment course to ensure early detection and intervention.


 	
Cardiotoxicity is the most serious concernLong-term use may lead to a decrease in heart function or heart failure, particularly in patients with prior heart issues or those receiving anthracyclines.

 	
Cumulative fatigue and weaknessPatients on Herceptin for extended periods may experience chronic fatigue, impacting quality of life and daily functioning.

 	
Immune suppressionProlonged use of Herceptin, especially in combination with chemotherapy, may affect immune response, increasing susceptibility to infections.

 	
Potential liver function abnormalitiesRarely, long-term therapy may result in elevated liver enzymes or hepatic dysfunction, which requires monitoring through blood tests.

 	
Infusion reactions remain a riskEven after months of therapy, patients can still experience infusion-related side effects, although the severity typically decreases over time.

 	
Increased cost and logistical burdenExtended therapy means more infusions, follow-up appointments, and ongoing access to refrigerated storage and delivery — all of which can be taxing without adequate support.

Question 13

Can I travel while on Herceptin?

Accepted Answer

Yes, it’s possible to travel while undergoing Herceptin treatment, but it requires careful coordination and planning. Because Herceptin is administered via IV and needs consistent dosing schedules, patients must prepare for treatment continuity while away from their usual healthcare facility.


 	
Coordinate with your oncologist before travelingYour doctor can help you arrange infusions in another clinic or hospital near your travel destination to avoid missed doses.

 	
Bring a treatment schedule and medical recordsAlways carry a printed or digital copy of your dosing history, current treatment plan, and emergency contacts in case you're treated by unfamiliar providers.

 	
Plan refrigeration logistics if transporting vialsIf you’re carrying your own medication (in rare cases), ensure it remains between 2°C–8°C at all times using certified portable medical coolers.

 	
Account for local medical regulationsDifferent countries have different rules about transporting and using prescription medications. Carry appropriate documentation if traveling internationally.

 	
Use travel insurance that covers medical treatmentIn case of emergencies or required infusion sessions abroad, insurance can help offset unexpected medical expenses.

 	
Avoid missing doses due to scheduling conflictsPlan travel around infusion days, and make sure to account for time zones when organizing your next appointment.

Question 14

What happens if Herceptin gets warm during transit?

Accepted Answer

Herceptin must remain within a strict temperature range (2°C to 8°C) to ensure its effectiveness. If the medication is exposed to temperatures outside this range, especially above 25°C or below freezing, the protein structure may degrade, making it unsafe or ineffective for use.


 	
Temperature excursions can reduce drug efficacyIf Herceptin becomes too warm or frozen during transit, it may no longer bind properly to the HER2 receptor, reducing therapeutic effect.

 	
Do not use if package is warm upon arrivalIf the shipping container feels warm to the touch or you suspect a temperature breach, do not use the product. Contact us immediately.

 	
We offer temperature-controlled shippingAll our Herceptin orders are shipped using insulated cold-chain packaging with medical-grade cold packs and minimal transit time.

 	
Check for temperature indicators if providedSome shipments include a color-changing tag or temperature sensor — review it upon arrival to verify cold-chain compliance.

 	
We will replace compromised shipmentsAt NovaScript Pharmacy, we stand behind our quality. If a shipment arrives outside of safe temperature parameters, we offer a full replacement at no extra cost.

 	
Store in refrigerator immediately upon receiptOnce the package arrives, the product should be placed in a refrigerator right away to maintain continued potency.

Question 15

Can I self-administer Herceptin?

Accepted Answer

No, Herceptin cannot be self-administered. It must be given as an intravenous (IV) infusion in a clinical setting under the supervision of trained healthcare professionals. Administering Herceptin on your own is not safe due to the risk of infusion reactions and the complexity of preparation.


 	
Requires reconstitution and dilutionHerceptin is supplied as a lyophilized powder that must be reconstituted with sterile water and then diluted before IV infusion.

 	
Infusion must be carefully timedThe infusion rate, especially during the first dose, needs to be slow and controlled to reduce the risk of hypersensitivity reactions.

 	
Medical monitoring is essentialVital signs such as blood pressure, heart rate, and oxygen saturation must be monitored before, during, and after infusion.

 	
Premedication may be requiredAntihistamines, acetaminophen, or corticosteroids are often administered beforehand to reduce side effects, and this must be done under supervision.

 	
Emergency equipment must be availableIn the rare event of anaphylaxis or severe reaction, immediate medical intervention is required — this cannot be provided at home.

 	
Only qualified personnel can handle preparationHandling biologics like Herceptin requires sterile technique and knowledge of safe disposal procedures for cytotoxic drugs.

Question 16

What are the signs of an allergic reaction to Herceptin?

Accepted Answer

Although uncommon, allergic or hypersensitivity reactions to Herceptin can occur, particularly during or shortly after the infusion. These reactions may range from mild to life-threatening and require immediate recognition and treatment. Patients are typically monitored closely during administration to identify and manage any symptoms promptly.


 	
Skin reactions like rash or hivesRedness, itching, or swelling of the skin is a common early sign of an allergic response. Hives may appear on the face, chest, or arms.

 	
Difficulty breathing or shortness of breathRespiratory symptoms are a serious concern and may indicate bronchospasm or airway constriction caused by an immune reaction.

 	
Swelling of face, lips, or tongueFacial angioedema is a classic symptom of a severe allergic reaction and requires immediate medical attention.

 	
Low blood pressure or dizzinessHypotension or a drop in blood pressure can cause lightheadedness, fainting, or confusion, signaling an anaphylactic response.

 	
Tightness in the chest or wheezingThis may mimic asthma and typically indicates narrowing of airways during a systemic allergic event.

 	
Nausea, vomiting, or abdominal crampingWhile these can occur from infusion side effects, they may also be part of a larger allergic presentation if accompanied by other symptoms.

Question 17

Is Herceptin safe with other cancer treatments?

Accepted Answer

Yes, Herceptin is often combined with other cancer therapies to increase treatment effectiveness. It is frequently used alongside chemotherapy, hormonal therapy, radiation, or other biologic agents. However, combining treatments requires careful monitoring to avoid additive toxicity and manage overlapping side effects.


 	
Commonly used with chemotherapy agentsHerceptin is typically combined with docetaxel, paclitaxel, or carboplatin to improve overall response rates in HER2-positive cancers.

 	
Used with Perjeta for dual HER2 inhibitionCombining Herceptin with Pertuzumab offers a more comprehensive blockade of the HER2 signaling pathway and is often used in advanced breast cancer.

 	
Can be paired with hormonal therapiesIn HER2-positive and hormone receptor-positive cancers, Herceptin may be given alongside drugs like tamoxifen or aromatase inhibitors.

 	
Radiation therapy compatibilityHerceptin can be safely administered with radiation in many cases, although the timing and sequence are carefully coordinated by the oncologist.

 	
Requires heart monitoring when combined with anthracyclinesWhen used with drugs like doxorubicin, the risk of cardiac toxicity increases, necessitating more frequent heart function testing.

 	
No major pharmacokinetic interactionsHerceptin does not significantly alter the metabolism of other drugs, but additive side effects are possible and should be anticipated.

Question 18

What is the difference between Herceptin and Perjeta?

Accepted Answer

Herceptin and Perjeta are both monoclonal antibodies that target the HER2 receptor, but they act on different regions and have different mechanisms of action. They are often used together for a more robust anti-cancer effect, especially in aggressive or advanced-stage HER2-positive breast cancers.


 	
Different binding sites on HER2Herceptin binds to domain IV of the HER2 receptor, while Perjeta binds to domain II. This dual action prevents receptor activation and dimerization.

 	
Herceptin prevents signaling; Perjeta blocks pairingHerceptin stops downstream signaling, while Perjeta prevents HER2 from pairing with other HER family receptors, especially HER3.

 	
Used in combination for superior outcomesThe combination of Herceptin and Perjeta has shown improved progression-free survival and overall response rates compared to Herceptin alone.

 	
Different side effect profilesPerjeta is more commonly associated with diarrhea, rash, and low white blood cell counts, while Herceptin has a higher risk of cardiotoxicity.

 	
Both require IV administrationBoth drugs are given via infusion and are often administered sequentially or together in the same treatment session.

 	
Not interchangeableEach drug serves a unique function in HER2 blockade and cannot replace the other. Combination therapy is often the gold standard in advanced cases.

Question 19

How soon can I expect results from Herceptin?

Accepted Answer

The response time to Herceptin can vary widely depending on the cancer type, treatment setting (early-stage vs. metastatic), and whether it’s used alone or with chemotherapy. Clinical improvements may begin within weeks, but complete results often take several cycles to evaluate properly.


 	
Tumor shrinkage can occur within 6–8 weeksIn many patients, early imaging or physical exams reveal tumor reduction after just two to three treatment cycles.

 	
Blood markers and scans track progressOncologists use tumor markers, CT scans, PET scans, and physical exams to monitor how well the tumor is responding to treatment.

 	
Combination therapy accelerates responseWhen used with chemotherapy, Herceptin may produce faster and more dramatic responses than when used alone.

 	
Response may be slower in maintenance therapyWhen used after initial treatment to maintain remission, visible tumor shrinkage may not occur because the tumor is already gone or stable.

 	
Long-term use sustains remissionContinued therapy over months may not yield new shrinkage but helps prevent recurrence or progression.

 	
Every patient is differentGenetic factors, tumor biology, and prior treatment history all affect how quickly and how strongly a patient responds to Herceptin.

Question 20

What should I do if I vomit after an infusion?

Accepted Answer

Vomiting after a Herceptin infusion is not uncommon, particularly if it is administered with chemotherapy. While vomiting itself is not typically dangerous, it can indicate an infusion reaction, drug intolerance, or dehydration. It’s important to report this to your medical team for proper assessment.


 	
Inform your oncologist or infusion nurse immediatelyRepeated vomiting may require antiemetic (anti-nausea) medication or a change in your infusion protocol.

 	
Monitor for accompanying symptomsIf vomiting is accompanied by fever, rash, or shortness of breath, it could signal a more serious reaction that needs urgent care.

 	
Drink fluids to prevent dehydrationVomiting leads to fluid and electrolyte loss. Rehydrating with water, oral rehydration solutions, or electrolyte-rich drinks is essential.

 	
Track frequency and severityKeep a record of when vomiting occurs and how severe it is. This helps guide treatment decisions for future infusions.

 	
Premedication may help reduce recurrenceIf vomiting occurs consistently, doctors may prescribe anti-nausea drugs before the next infusion to improve tolerability.

 	
Infusion rate may be adjustedSlowing the infusion rate or spacing out combination therapies may help reduce nausea and vomiting in sensitive patients.

NovaScript Pharmacy

NovaScript Pharmacy

Shop

Buy Herceptin online

Buy Humira Pens Online

Buy Hydrocodone Online

Buy Hydromorphone online

Buy Hydroquinone online

Buy Intuniv Online

Buy Invokana Online

Buy Isotretinoin online

Buy Januvia Online

Buy Jeuveau online

Buy Juvéderm online

Buy Kamagra Online

Buy Kapvay Online

Buy Keytruda Online

Buy Lanoxin Online

Buy Lantus Online